5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier

Product Details
Customization: Available
Application: Treat Severe Diabetic Gastroparesis
Usage Mode: Injection
Still deciding? Get samples of US$ 5/Piece
Request Sample
Gold Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
In-stock Capacity
The supplier has In-stock capacity
100% Finished Products Inspection
The supplier inspects 100% of finished products.
to see all verified strength labels (17)
  • 5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier
  • 5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier
  • 5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier
  • 5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier
  • 5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier
  • 5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier
Find Similar Products
  • Overview
  • DESCRIPTION
  • Clinical Pharmacology
  • Usage and Dosage
  • Detailed Photos
  • Storage
  • More injections we produce
  • Company Profile
Overview

Basic Info.

Model NO.
5mg/ml
Suitable for
All
State
Liquid
Shape
Oral Liquid
Type
Biological Products
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
300490
Drug Ad Approval No.
300490
Class
Pharmaceutical
Registration Dosser
Available
Packing Label
Customizable
Standard
Cp, USP, Bp
Transport Package
Box
Specification
10x2ml
Trademark
SHENGLU
Origin
China
HS Code
2920901900
Production Capacity
100000000000000/Year

Product Description


5mg/ml Metoclopramide injection finished medicine with GMP Certificate Supplier
DESCRIPTION

Metoclopramide increases muscle contractions in the upper digestive tract. This speeds up the rate at which the stomach empties into the intestines.

Metoclopramide oral (taken by mouth) is used for 4 to 12 weeks to treat heartburn caused by gastroesophageal reflux in people who have used other medications without relief.

Generic name:  metoclopramide (oral/injection) 
Brand names: Metozolv ODT, Reglan
Parenteral: injectable solution (10 mg/mL; 10 mg/mL preservative-free; 4 mg/mL), intravenous solution (6 mg/25 mL-NaCl 0.9%)
Oral: 10 mg 4 times daily, 30 minutes before meals and at bedtime, for 2 to 8 weeks depending on clinical response.
Drug class:   GI stimulants, Miscellaneous antiemetics
Clinical Pharmacology

MetoclopramideInjection is a clear, colourless solution in a plastic ampoule. Metoclopramide Injection 10 mg in 2 mL is available in packs of 10 or 50 ampoules (AUST R 11364) * Not all pack sizes may be marketed.
 

Usage and Dosage

Usual Adult Dose for Nausea/Vomiting:

Postoperative nausea and vomiting:
Parenteral: 10 to 20 mg IM at or near the end of surgery

Usual Adult Dose for Gastroesophageal Reflux Disease:

Oral: 10 to 15 mg up to 4 times a day 30 minutes before meals and at bedtime, depending upon symptoms being treated and clinical response. Therapy should not exceed 12 weeks.

Usual Adult Dose for Small Intestine Intubation:

If the tube has not passed the pylorus with conventional methods in 10 minutes, a single (undiluted) dose may be administered IV slowly over 1 to 2 minutes:
Adults and pediatric patients greater than or equal to 14 years: 10 mg IV as a single dose administered over 1 to 2 minutes.

Usual Adult Dose for Radiographic Exam:

Adults and pediatric patients greater than or equal to 14 years: 10 mg IV as a single dose administered over 1 to 2 minutes to facilitate gastric emptying where delayed gastric emptying interferes with radiological examination of the stomach and/or small intestine.

Usual Adult Dose for Gastroparesis:

During the earliest manifestations of diabetic gastric stasis, oral administration may be initiated. If severe symptoms are present, therapy should begin with IM or IV administration for up to 10 days until symptoms subside at which time the patient can be switched to oral therapy. Since diabetic gastric stasis is often recurrent, therapy should be reinstituted at the earliest manifestation.

Parenteral: 10 mg 4 times daily, IV (slowly over a 1 to 2 minute period) or IM for up to 10 days.

Oral: 10 mg 4 times daily, 30 minutes before meals and at bedtime, for 2 to 8 weeks depending on clinical response.

Detailed Photos

5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier

5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier

Storage

Store tightly away from light.

More injections we produce

5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier

Company Profile

5mg/Ml Metoclopramide Injection Finished Medicine with GMP Certificate Supplier

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier